30-day FRN pub 12-09-2014 1615-0030 I-612

rljohnson on DSK3VPTVN1PROD with NOTICES

73092

Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices

4. Australian Patent 2009231978,
issued February 20, 2014, titled ‘‘Purine
Derivatives As A3 Adenosine ReceptorSelective Agonists’’ [HHS Ref. No. E–
140–2008/0–AU–03];
5. U.S. Patent Application 13/371,081,
filed February 10, 2012, titled ‘‘A3
Adenosine Receptor Agonists And
Antagonists’’ [HHS Ref. No. E–140–
2008/1–US–01];
6. U.S. Provisional Application 61/
909,742, filed November 27, 2013, titled
‘‘A3 Adenosine Receptor Agonists’’
[HHS Ref. No. E–742–2013/0–US–01];
and
7. U.S. Provisional Application 62/
033,723, filed August 6, 2014, titled ‘‘A3
Adenosine Receptor Agonists’’ [HHS
Ref. No. E–210–2014/0–US–01].
The patent rights in these inventions
either have been assigned to the
Government of the United States of
America, or have been granted exclusive
rights to the Government of the United
States of America. The territory of the
prospective Start-up Exclusive
Evaluation Option License Agreement
may be worldwide, and the field of use
may be limited to: ‘‘The use of an A3
Adenosine Receptor (A3AR) agonist as
an orally-administered analgesic, either
as monotherapy or as an add-on
analgesic, for treatment of chronic
neuropathic pain conditions’’.
Upon the expiration or termination of
the Start-up Exclusive Evaluation
Option License Agreement,
BioIntervene will have the exclusive
right to execute a Start-up Exclusive
Patent License Agreement which will
supersede and replace the Start-up
Exclusive Evaluation Option License
Agreement, with no greater field of use
and territory than granted in the Startup Exclusive Evaluation Option License
Agreement.
DATES: Only written comments and/or
applications for a license which are
received by the NIH Office of
Technology Transfer on or before
December 24, 2014 will be considered.
ADDRESSES: Requests for copies of the
patents, patent applications, inquiries,
comments, and other materials relating
to the contemplated Start-Up Exclusive
Evaluation Option License Agreement
should be directed to: Betty B. Tong,
Ph.D., Senior Licensing and Patenting
Manager, Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; Telephone:
(301) 594–6565; Facsimile: (301) 402–
0220; Email: [email protected]. A
signed confidentiality nondisclosure
agreement will be required to receive
copies of any patent applications that
have not been published or issued by

VerDate Sep<11>2014

14:48 Dec 08, 2014

Jkt 235001

the United States Patent and Trademark
Office or the World Intellectual Property
Organization.
SUPPLEMENTARY INFORMATION: The
subject inventions describe selective A3
Adenosine Receptor (A3AR) agonists,
and their in vivo activity reducing or
preventing development of chronic
neuropathic pain in an animal model.
The A3AR subtype was linked with
helping protect the heart from ischemia,
controlling inflammation, and
regulating cell proliferation. The
compounds claimed are consistently
highly selective and have smaller
molecular weight, thus can offer greater
oral bioavailability. Hence, the subject
inventions may provide a new treatment
for chronic neuropathic pain.
The prospective Start-up Exclusive
Evaluation Option License Agreement
and a subsequent Start-up Exclusive
Patent License Agreement may be
granted unless the NIH receives written
evidence and argument, within fifteen
(15) days from the date of this published
notice, that establishes that the grant of
the contemplated Start-up Exclusive
Evaluation Option License Agreement
would not be consistent with the
requirements of 35 U.S.C. 209 and 37
CFR part 404.
Complete applications for a license in
the prospective field of use that are filed
in response to this notice will be treated
as objections to the grant of the
contemplated Start-Up Exclusive
Evaluation Option License Agreement.
Comments and objections submitted in
response to this notice will not be made
available for public inspection and, to
the extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
Dated: December 3, 2014.
Richard U. Rodriguez,
Acting Director, Office of Technology
Transfer, National Institutes of Health.
[FR Doc. 2014–28749 Filed 12–8–14; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0030]

Agency Information Collection
Activities: Application for Waiver of the
Foreign Residence Requirement of
Section 212(e) of the Immigration and
Nationality Act, Form I–612; Revision
of a Currently Approved
ACTION:

PO 00000

30-Day Notice.

Frm 00067

Fmt 4703

Sfmt 4703

The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection notice
was previously published in the Federal
Register on September 10, 2014, at 79
FR 53720, allowing for a 60-day public
comment period. USCIS did receive 1
comment in connection with the 60-day
notice.
DATES: The purpose of this notice is to
allow an additional 30 days for public
comments. Comments are encouraged
and will be accepted until January 8,
2015. This process is conducted in
accordance with 5 CFR 1320.10.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, must be
directed to the OMB USCIS Desk Officer
via email at oira_submission@
omb.eop.gov. Comments may also be
submitted via fax at (202) 395–5806. All
submissions received must include the
agency name and the OMB Control
Number 1615–0030.
You may wish to consider limiting the
amount of personal information that you
provide in any voluntary submission
you make. For additional information
please read the Privacy Act notice that
is available via the link in the footer of
http://www.regulations.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:

Comments:
Note: The address listed in this notice
should only be used to submit
comments concerning this information
collection. Please do not submit
requests for individual case status
inquiries to this address. If you are
seeking information about the status of
your individual case, please check ‘‘My
Case Status’’ online at: https://
egov.uscis.gov/cris/Dashboard.do, or
call the USCIS National Customer
Service Center at 1–800–375–5283.
Written comments and suggestions
from the public and affected agencies
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,

E:\FR\FM\09DEN1.SGM

09DEN1

Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices

rljohnson on DSK3VPTVN1PROD with NOTICES

including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection
Request: Revision of a Currently
Approved Collection.
(2) Title of the Form/Collection:
Application for Waiver of the Foreign
Residence Requirement of Section
212(e) of the Immigration and
Nationality Act.
(3) Agency form number, if any, and
the applicable component of the DHS
sponsoring the collection: I–612; USCIS.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
households. This information collection
is necessary and may be submitted only
by an alien who believes that
compliance with foreign residence
requirements would impose exceptional
hardship on his or her spouse or child
who is a citizen of the United States, or
a lawful permanent resident; or that
returning to the country of his or her
nationality or last permanent residence
would subject him or her to persecution
on account of race, religion, or political
opinion. Certain aliens admitted to the
United States as exchange visitors are
subject to the foreign residence
requirements of section 212(e) of the
Immigration and Nationality Act (the
Act). Section 212(e) of the Act also
provides for a waiver of the foreign
residence requirements in certain
instances.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: The estimated total number of
respondents for the information
collection I–612 is 1,300 and the
estimated hour burden per response is
.333 hours.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total estimated annual
hour burden associated with this
collection is 433 hours.
If you need a copy of the information
collection instrument with
supplementary documents, or need
additional information, please visit

VerDate Sep<11>2014

14:48 Dec 08, 2014

Jkt 235001

http://www.regulations.gov. We may
also be contacted at: USCIS, Office of
Policy and Strategy, Regulatory
Coordination Division, 20
Massachusetts Avenue NW,
Washington, DC 20529–2134;
Telephone 202–272–8377.
Dated: December 3, 2014.
Laura Dawkins,
Chief, Regulatory Coordination Division,
Office of Policy and Strategy, U.S. Citizenship
and Immigration Services, Department of
Homeland Security.
[FR Doc. 2014–28781 Filed 12–8–14; 8:45 am]
BILLING CODE 9111–97–P

DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0063]

Agency Information Collection
Activities: National Interest Waivers,
Supplemental Evidence to I–140 and I–
485, No Agency Form Number;
Extension, Without Change, of a
Currently Approved Collection
ACTION:

*

30-day Notice.

*

*
*
*
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The information collection notice
was previously published in the Federal
Register on August 8, 2014, at 79 FR
46447, allowing for a 60-day public
comment period. USCIS did not receive
any comments in connection with the
60-day notice.
DATES: The purpose of this notice is to
allow an additional 30 days for public
comments. Comments are encouraged
and will be accepted until January 8,
2015. This process is conducted in
accordance with 5 CFR 1320.10.
ADDRESSES: Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, must be
directed to the OMB USCIS Desk Officer
via email at oira_submission@
omb.eop.gov. Comments may also be
submitted via fax at (202) 395–5806. All
submissions received must include the
agency name and the OMB Control
Number 1615–0063.
You may wish to consider limiting the
amount of personal information that you
SUMMARY:

PO 00000

Frm 00068

Fmt 4703

Sfmt 4703

73093

provide in any voluntary submission
you make. For additional information
please read the Privacy Act notice that
is available via the link in the footer of
http://www.regulations.gov.
SUPPLEMENTARY INFORMATION:
Comments
Note: The address listed in this notice
should only be used to submit comments
concerning this information collection.
Please do not submit requests for individual
case status inquiries to this address. If you
are seeking information about the status of
your individual case, please check ‘‘My Case
Status’’ online at: https://egov.uscis.gov/cris/
Dashboard.do, or call the USCIS National
Customer Service Center at 1–800–375–5283.

Written comments and suggestions
from the public and affected agencies
should address one or more of the
following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of this Information Collection
(1) Type of Information Collection
Request: Extension, Without Change, of
a Currently Approved Collection.
(2) Title of the Form/Collection:
National Interest Waivers, Supplemental
Evidence to I–140 and I–485.
(3) Agency form number, if any, and
the applicable component of the DHS
sponsoring the collection: No Agency
Form Number; USCIS.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Individuals or
households. The supplemental
documentation will be used by the U.S.
Citizenship and Immigration Services to
determine eligibility for national
interest waiver requests for physicians
and to finalize the request for
adjustment to lawful permanent
resident status.

E:\FR\FM\09DEN1.SGM

09DEN1